The Prognostic Value of Low HER2 Expression on Treatment Outcomes in Metastatic Hormone Receptor-positive Breast Cancer Patients Treated with CDK4/6 Inhibitors and Endocrine Therapy.

Subjects

Subjects :

*THERAPEUTIC use of antineoplastic agents
*HORMONE receptor positive breast cancer
*TUMOR markers
*TREATMENT effectiveness
*CONFERENCES & conventions
*CANCER patients
*GENE expression
*ONCOGENES
*CYCLIN-dependent kinases
*EVALUATION
*CHEMICAL inhibitors

Details

Language :

English

ISSN :

09366555

Volume :

36

Issue :

4

Database :

Academic Search Index

Journal :

Clinical Oncology

Publication Type :

Academic Journal

Accession number :

175908164

Full Text :

https://doi.org/10.1016/j.clon.2024.01.029